Perbedaan Organon Pharma Indonesia Tbk. dan Yupi Indo Jelly Gum Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Yupi Indo Jelly Gum Tbk. diperdagangkan di Rp1.300 (kapitalisasi pasar 11,36 T, volume 24 jam 22 rb). Perbedaan utamanya: Yupi Indo Jelly Gum Tbk. jauh lebih besar — sekitar 108,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | YUPI | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 11,36 T |
Volume | — | 22 rb |
Lot | — | 220 |
Perputaran | — | 28,74 jt |
Harga Rata-rata | — | 1.306,27 |
Nilai Transaksi | — | 28,74 jt |
Harga Ekuilibrium Indikatif | — | 1.330 |
Volume Ekuilibrium Indikatif | — | 100 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT. Yupi Indo Jelly Gum Tbk. (the Company) was established in Republic Indonesia dated July 6, 1995 based on Notarial Deed No. 38 of Sutjipto, S.H., dated July 6, 1995. The Company parent entity and ultimate parent entity are PT. Sweets Indonesia and PT. Cipta Astana Gemilang, respectively.
Selengkapnya di halaman YUPI →